| Application no. and date | 99304374.4 (espacenet) (Federated) (European Patent Register), 19990604 | | Patent/reg. no. and date | DK/EP 0966968, 20040506 | | Publication date | 19991229 | | Priority no. and date | US 89468 P, 19980616 | | EP pub. no. and date |
EP 0966968 19991229 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton, CT 06340-5146, US | | Applicant ref. no. | P200400724 EP DK | | Inventor | Ke, Hua Zhu, 2 Deer Lane
Ledyard,
Connecticut 06339, US,
Thompson, David Duane, 37 Bittersweet Drive
Gales Ferry,
Connecticut 06335, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/40, A61K 31/557 | | Title | Terapeutiske kombinationer, der omfatter en selektiv østrogenreceptormodulator og prostaglandin E2 | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
